Emfizema legkikh: sovremennyy vzglyad


Cite item

Full Text

Abstract

Для российского врача в связи с формированием в последнее время концепции хронической обструктивной болезни легких (ХОБЛ), изменившей не только терминологию, но и принципиальное понимание патологических механизмов у таких больных, тем более актуально обсуждение различных аспектов легочной эмфиземы.За последние 10 лет произошли существенные изменения как в понимании патогенетических процессов, лежащих в основе эмфиземы, так и в разработке новых подходов к ведению больных. Современные технологии дают возможность уменьшить симптомы заболевания, улучшить качество и продолжительность жизни пациентов с легочной эмфиземой.

About the authors

A. V Aver'yanov

НИИ пульмонологии Росздрава, Москва

References

  1. National Heart Lung and Blood Institute. The definition of emphysema. Report of a Division of Lung Diseases workshop. Am Rev Respir Dis 1985; 132: 182-5.
  2. Mason R.J, Murray J.F, Broaddus V.C, Nadel J.A. Textbook of Respiratory Medicine. Fourth Edition, Elsevier inc., USA, 2005; 1: 1117.
  3. Изаксон Э. О патолого - анатомических изменениях легочных сосудов при эмфизематозном процессе в легких. Пульмонология. 2005; 4.
  4. Harris W.H, Chillingworth F.P. The experimental production in dogs of emphysema with associated asthmatic syndrome by means of an intratracheal ball valve. J Exp Med 1919; 30: 75-85.
  5. Laurell C.B, Erickson S. The electrophoretic a1-globulin pattern of serum in a1-antitrypsin deficiency. Scan J Clin Lab Invest 1963; 15: 132-40.
  6. Gross P, Babjak M, Tolker E et al. Enzymatically produced pulmonary emphysema: A preliminary report. J Occup Med 1964; 6: 481-4.
  7. Mercer R, Crapo J.D. Structural changes in elastic fibers after pancreatic elastase administration in hamsters. J Appl Physiol 1992; 72: 1473-9.
  8. Shapiro S.D, Ingenito E.P. The Pathogenesis of Chronic Obstructive Pulmonary Disease: Advances in the Past 100 Years. Am J Respir Cell Mol Biol 2005; 32 (5): 367-72.
  9. Segura-Valdez L, Pardo A, Gaxiola M et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-94.
  10. Chapman K.R, Stockley R.A, Dawkins C et al. Augmentation therapy for a1-antitrypsin deficiency: a meta - analysis of randomized and non - randomized clinical studies. Eur Respir J 2005; 26 (49): 288.
  11. Vlanovich G, Russel M.L, Mercer R.R, Crapo J.D. Cellular and Connective Tissue Changes in Alveolar Septal Walls in Emphysema. Am J Respir Crit Care Med 1999; 160 (6): 2086-92.
  12. Massaro G.D, Radaeva S, Clerch L.B, and Massaro D. Lung alveoli: endogenous programmed destruction and regeneration. Am J Physiol Lung Cell Mol Physiol 2002; 283: 305-9.
  13. Barnes P.J, Stockley R.A. COPD: current therapeutic interventions and future approaches. Eur Rroaches. Eur Respir J 2005; 25: 1084-106.
  14. Theegarten D, Mogilevski G, Anhem O et al. The role of Chlamydia in the pathogenesis of pulmonary emphysema. Virchows Arch 2000; 437: 190-3.
  15. Kol A, Sukhova G.K, Lichtman A.H et al. Chlamydia l heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor - a and matrix metalloproteinase expression. Circulation 1998; 98: 300-7.
  16. Tudern R.M, Zhen L, Cho C.Y. Oxidative Stress and Apoptosis Interact and Cause Emphysema Due to Vascular Endothelial Growth Factor Receptor Blockade. Am J of Respir Cell and Molec Biol 2003; 29: 88-97.
  17. Voelkel N.F, Vandivier R.W, Tuder R.M.Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 2006; 290 (2): L209-21.
  18. Voelkel N.F, Taraseviciene-Stewart L. Emphysema An Autoimmune Vascular Disease? Proceed Am Thorac Society 2005; 2: 23-5.
  19. Smedly L.A, Tonnesen M.G, Sandhaus R.A et al. Neutrophil - mediated injury to endothelial cells - enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 1986; 77: 1233-43.
  20. Harlan J.M, Killen P.D, Harker L.A et al. Neutrophil - mediated endothelial injury in vitro. J Clin Invest 1981; 68: 1394-403.
  21. Choe K.H, Taraseviciene-Stewart L, Scerbavicius R et al. Methylprednisolone causes matrix metalloproteinase - dependent emphysema in adult rats. Am J Respir Crit Care Med 2003; 167: 1516-21.
  22. Stein J, Fenigstein H. Pathological anatomy of hunger disease. In: Winick M, editor. Hunger disease: studies by the Jewish physicians in the Warsaw Ghetto: current concepts in nutrition. New York: John Wiley & Sons; 1979; p. 207-11.
  23. Kerr J.S, Riley D.J, Lanza-Jacoby S et al. Nutritional emphysema in the rat. Am Rev Respir Dis 1985; 131: 644-50.
  24. Coxson H, Ida H, Chan T, Mayo J. Early Emphysema in Patients with Anorexia Nervosa. Am J Respir Crit Care Med 2004; 170: 748-52.
  25. Uppaluri R, Mitsa T, Sonka M et al. Quantification of pulmonary emphysema from lung computed tomography images. Am J Respir Crit Care Med 1997; 156: 248-54.
  26. Власов П.В. Лучевая диагностика заболеваний органов грудной полости. Видар, 2006; с. 65-77.
  27. Gevenois P.A, De Vuyst P, de Maertelaer V, Zanen et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit CareMed 1996; 154: 187-92.
  28. Wencker M, Fuhrmann B, Banik N et al. Longitudinal follow - up of patients with alpha(1)- protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001; 119: 737-44.
  29. Strange C, Dickson R, Cartier C et al. Survival and FEV1 decline in individuals with severe deficiency of alpha-1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1998; 158: 49-59.
  30. Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 2000; 118: 1480-5.
  31. Troosters T, Gosselink R, Decramer M. Short - and long - term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109: 207-12.
  32. Finnerty J.P, Keeping I, Bullough I, Jones J. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: randomized controlled trial. Chest 2001; 119: 1705-10.
  33. Brantigan O, Mueller E Surgical treatment of pulmonary emphysema. Am Surg 1957; 23: 789-804.
  34. Cooper J.D, Trulock E.P, Triantafillou A.N et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-16.
  35. Meyers B.F, Yusen R.D, Guthrie T.J et al. Results of lung volume reduction surgery in patients meeting a national emphysema treatment trial high - risk criterion. J Thorac Cardiovasc Surg 2004; 127: 829-35.
  36. Tutic M, Lardinois D, Imfeld S. Lung-Volume Reduction Surgery as an Alternative or Bridging Procedure to Lung Transplantation Ann Thorac Surg 2006; 82: 208-13

Copyright (c) 2006 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies